Original Research
Published on 12 Jan 2023
The use of cyclic peptide antigens to generate LRP8 specific antibodies
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1093153
- 2,132 views
- 2 citations
Volumes
50 Publications
Brief Research Report
Published on 09 Jan 2023
Determination of nucleoside DOT1L inhibitors’ residence times by τRAMD simulations
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1083198
- 1,550 views
- 1 citation
Brief Research Report
Published on 05 Jan 2023
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1082065
- 2,434 views
- 2 citations
Editorial
Published on 05 Jan 2023
Editorial: Insights in silico methods and artificial intelligence for drug discovery: 2022
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1126955
- 1,753 views
- 1 citation
Original Research
Published on 23 Dec 2022
Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1085701
- 1,347 views
- 2 citations
Methods
Published on 19 Dec 2022
Enhanced utility of AI/ML methods during lead optimization by inclusion of 3D ligand information
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1074797
- 4,799 views
- 4 citations
Review
Published on 15 Dec 2022
Novel and emerging therapies in pulmonary arterial hypertension
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1022971
- 8,158 views
- 3 citations
Original Research
Published on 12 Dec 2022
In silico mapping of the dynamic interactions and structure-activity relationship of flavonoid compounds against the immune checkpoint programmed-cell death 1 pathway
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1032587
- 3,016 views
- 4 citations
Mini Review
Published on 08 Dec 2022
Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1043617
- 6,066 views
- 6 citations
Review
Published on 07 Dec 2022
The landscape of nature-derived antimalarials-potential of marine natural products in countering the evolving Plasmodium
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1065231
- 2,315 views
- 4 citations
Review
Published on 06 Dec 2022
Coumarin-1,2,3-triazole hybrids as leading-edge anticancer agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1072448
- 3,623 views
- 13 citations
Original Research
Published on 29 Nov 2022
ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1050687
- 1,805 views
Mini Review
Published on 03 Nov 2022
Oxidized phospholipids are biomarkers, drug targets, and drug leads
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1043708
- 2,434 views
- 4 citations
Review
Published on 02 Nov 2022
Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1013285
- 4,638 views
- 7 citations
Original Research
Published on 25 Oct 2022
Network pharmacology and molecular docking to explore Siraitia grosvenorii’s potential mechanism in preventing and treating proliferative diabetic retinopathy
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1038224
- 1,662 views
- 1 citation
Systematic Review
Published on 25 Oct 2022
Characterization of KLH-driven immune responses in clinical studies: A systematic review
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.992087
- 6,092 views
- 3 citations